Capstone Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $269K | Sell |
16,739
-2,040
| -11% | -$32.8K | 0.01% | 1342 |
|
|
2017
Q1 | $238K | Sell |
18,779
-1,990
| -10% | -$25.2K | 0.01% | 1446 |
|
|
2016
Q4 | $275K | Sell |
20,769
-3,390
| -14% | -$44.9K | 0.01% | 1368 |
|
|
2016
Q3 | $573K | Buy |
24,159
+660
| +3% | +$15.7K | 0.02% | 865 |
|
|
2016
Q2 | $677K | Buy |
23,499
+1,850
| +9% | +$53.3K | 0.02% | 756 |
|
|
2016
Q1 | $693K | Sell |
21,649
-740
| -3% | -$23.7K | 0.02% | 722 |
|
|
2015
Q4 | $957K | Buy |
22,389
+420
| +2% | +$18K | 0.03% | 617 |
|
|
2015
Q3 | $774K | Buy |
21,969
+1,410
| +7% | +$49.7K | 0.02% | 649 |
|
|
2015
Q2 | $944K | Sell |
20,559
-12,830
| -38% | -$589K | 0.03% | 608 |
|
|
2015
Q1 | $1.57M | Buy |
33,389
+1,870
| +6% | +$87.7K | 0.04% | 483 |
|
|
2014
Q4 | $999K | Buy |
31,519
+3,460
| +12% | +$110K | 0.03% | 643 |
|
|
2014
Q3 | $665K | Sell |
28,059
-270
| -1% | -$6.4K | 0.02% | 824 |
|
|
2014
Q2 | $850K | Buy |
28,329
+3,794
| +15% | +$114K | 0.03% | 693 |
|
|
2014
Q1 | $648K | Sell |
24,535
-1,450
| -6% | -$38.3K | 0.02% | 867 |
|
|
2013
Q4 | $653K | Sell |
25,985
-13,821
| -35% | -$347K | 0.02% | 907 |
|
|
2013
Q3 | $815K | Buy |
39,806
+1,800
| +5% | +$36.9K | 0.02% | 918 |
|
|
2013
Q2 | $758K | Buy |
+38,006
| New | +$758K | 0.02% | 892 |
|